A repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodes.

Novel drugs are required for the elimination of infections caused by filarial worms, as most commonly used drugs largely target the microfilariae or first stage larvae of these infections. Previous studies, conducted in vitro, have shown that inhibition of Hsp90 kills adult Brugia pahangi. As numero...

Full description

Saved in:
Bibliographic Details
Main Authors: Victoria Gillan, Kerry O'Neill, Kirsty Maitland, Francis M Sverdrup, Eileen Devaney
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-02-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002699&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841527062487105536
author Victoria Gillan
Kerry O'Neill
Kirsty Maitland
Francis M Sverdrup
Eileen Devaney
author_facet Victoria Gillan
Kerry O'Neill
Kirsty Maitland
Francis M Sverdrup
Eileen Devaney
author_sort Victoria Gillan
collection DOAJ
description Novel drugs are required for the elimination of infections caused by filarial worms, as most commonly used drugs largely target the microfilariae or first stage larvae of these infections. Previous studies, conducted in vitro, have shown that inhibition of Hsp90 kills adult Brugia pahangi. As numerous small molecule inhibitors of Hsp90 have been developed for use in cancer chemotherapy, we tested the activity of several novel Hsp90 inhibitors in a fluorescence polarization assay and against microfilariae and adult worms of Brugia in vitro. The results from all three assays correlated reasonably well and one particular compound, NVP-AUY922, was shown to be particularly active, inhibiting Mf output from female worms at concentrations as low as 5.0 nanomolar after 6 days exposure to drug. NVP-AUY922 was also active on adult worms after a short 24 h exposure to drug. Based on these in vitro data, NVP-AUY922 was tested in vivo in a mouse model and was shown to significantly reduce the recovery of both adult worms and microfilariae. These studies provide proof of principle that the repurposing of currently available Hsp90 inhibitors may have potential for the development of novel agents with macrofilaricidal properties.
format Article
id doaj-art-e771bc9ec7164acf8dadc169bd1a26df
institution Kabale University
issn 1935-2727
1935-2735
language English
publishDate 2014-02-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-e771bc9ec7164acf8dadc169bd1a26df2025-01-16T05:32:27ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352014-02-0182e269910.1371/journal.pntd.0002699A repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodes.Victoria GillanKerry O'NeillKirsty MaitlandFrancis M SverdrupEileen DevaneyNovel drugs are required for the elimination of infections caused by filarial worms, as most commonly used drugs largely target the microfilariae or first stage larvae of these infections. Previous studies, conducted in vitro, have shown that inhibition of Hsp90 kills adult Brugia pahangi. As numerous small molecule inhibitors of Hsp90 have been developed for use in cancer chemotherapy, we tested the activity of several novel Hsp90 inhibitors in a fluorescence polarization assay and against microfilariae and adult worms of Brugia in vitro. The results from all three assays correlated reasonably well and one particular compound, NVP-AUY922, was shown to be particularly active, inhibiting Mf output from female worms at concentrations as low as 5.0 nanomolar after 6 days exposure to drug. NVP-AUY922 was also active on adult worms after a short 24 h exposure to drug. Based on these in vitro data, NVP-AUY922 was tested in vivo in a mouse model and was shown to significantly reduce the recovery of both adult worms and microfilariae. These studies provide proof of principle that the repurposing of currently available Hsp90 inhibitors may have potential for the development of novel agents with macrofilaricidal properties.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002699&type=printable
spellingShingle Victoria Gillan
Kerry O'Neill
Kirsty Maitland
Francis M Sverdrup
Eileen Devaney
A repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodes.
PLoS Neglected Tropical Diseases
title A repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodes.
title_full A repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodes.
title_fullStr A repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodes.
title_full_unstemmed A repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodes.
title_short A repurposing strategy for Hsp90 inhibitors demonstrates their potency against filarial nematodes.
title_sort repurposing strategy for hsp90 inhibitors demonstrates their potency against filarial nematodes
url https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002699&type=printable
work_keys_str_mv AT victoriagillan arepurposingstrategyforhsp90inhibitorsdemonstratestheirpotencyagainstfilarialnematodes
AT kerryoneill arepurposingstrategyforhsp90inhibitorsdemonstratestheirpotencyagainstfilarialnematodes
AT kirstymaitland arepurposingstrategyforhsp90inhibitorsdemonstratestheirpotencyagainstfilarialnematodes
AT francismsverdrup arepurposingstrategyforhsp90inhibitorsdemonstratestheirpotencyagainstfilarialnematodes
AT eileendevaney arepurposingstrategyforhsp90inhibitorsdemonstratestheirpotencyagainstfilarialnematodes
AT victoriagillan repurposingstrategyforhsp90inhibitorsdemonstratestheirpotencyagainstfilarialnematodes
AT kerryoneill repurposingstrategyforhsp90inhibitorsdemonstratestheirpotencyagainstfilarialnematodes
AT kirstymaitland repurposingstrategyforhsp90inhibitorsdemonstratestheirpotencyagainstfilarialnematodes
AT francismsverdrup repurposingstrategyforhsp90inhibitorsdemonstratestheirpotencyagainstfilarialnematodes
AT eileendevaney repurposingstrategyforhsp90inhibitorsdemonstratestheirpotencyagainstfilarialnematodes